Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy

Women with breast cancer who receive adjuvant therapy are at risk for developing therapy-related myelodysplastic syndrome (MDS) or AML (tMDS/AML). Patients with tMDS/AML are often referred for consideration of allogeneic hematopoietic SCT (HSCT). However, the outcomes of HSCT in such patients have n...

Full description

Saved in:
Bibliographic Details
Main Authors: Armand, P, Kim, HT, Mayer, E, Cutler, CS, Ho, VT, Koreth, J, Alyea, EP, Antin, JH, Soiffer, RJ
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889243/
https://ncbi.nlm.nih.gov/pubmed/20154738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2010.20
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items